Compliance & Medical Disclaimer

This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.

IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.

Reviewed by: WolveStack Research Team
Last reviewed: 2026-04-28
Editorial policy

Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.

Medical Disclaimer

For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.

Semaglutide requires careful temperature management: unopened pens refrigerated at 2-8°C (36-46°F) until first use, then can be stored at room temperature (15-30°C) for 28 days after opening. Reconstituted powder semaglutide must be refrigerated and is stable for 28 days. Heat above 30°C degrades the peptide rapidly; freezing causes irreversible damage. Never exceed the 28-day room temperature window.

What Are Semaglutide Storage Requirements?

Semaglutide is a temperature-sensitive peptide. Unopened prefilled pens must be refrigerated at 2-8°C (36-46°F) before first use. Once opened, pens can be stored at room temperature (15-30°C / 59-86°F) for up to 28 days from the date of first injection. For powder semaglutide, the lyophilized powder is stored refrigerated and, once reconstituted, must return to refrigeration at 2-8°C with 28-day stability from reconstitution.

How Long Is Semaglutide Stable at Room Temperature?

After the first injection from an opened pen, semaglutide remains stable at room temperature (15-30°C) for exactly 28 days. On day 29, the peptide begins degrading beyond manufacturer stability windows and pens should be discarded even if doses remain. This 28-day window is non-negotiable and based on stability studies at specified temperatures. If storage conditions were inconsistent or room temperature exceeded 30°C, the effective window shortens.

What Temperature Range Is Too Hot?

Semaglutide is significantly damaged by temperatures above 30°C (86°F). Leaving pens in cars (which can reach 60-70°C in summer), hot bathrooms, or direct sunlight dramatically accelerates degradation. Even brief exposure (a few hours in a hot car) compromises product integrity. Heat-damaged semaglutide may appear normal but will have reduced efficacy. Freezing also damages pens irreversibly.

How Should Semaglutide Be Transported?

When traveling, transport unopened pens in a cool bag with ice packs maintaining 2-8°C. For checked luggage, carry semaglutide in a temperature-controlled carry-on with ice packs or gel cooling elements. Airplane cargo holds fluctuate dangerously. For trips over 4 days, use a portable refrigerator or hotel room refrigerator. Many airports and hotels can store injectable medications in pharmacy refrigerators upon request.

Can Semaglutide Be Refrozen After Thawing?

No. If a refrigerated pen thaws and reaches room temperature, it cannot be refrozen. Thaw-freeze cycles denature peptides. Once thawed, semaglutide can be used immediately or stored at room temperature (2-30°C) for up to 28 days from when it reached room temperature. Do not refreeze under any circumstances.

What Does Degraded Semaglutide Look Like?

Degraded semaglutide often appears visually normal—heat or temperature damage may not cause visible discoloration or cloudiness. Never rely on visual inspection alone. Check before injection for: discoloration (should be clear), cloudiness or particles, cracks in the pen, or leakage. If present, discard immediately. The only reliable verification is proper storage adherence.

How Should Unopened Pens Be Stored?

Unopened pens must be refrigerated at 2-8°C from dispensing until first use. Store in the main body of the refrigerator, not in the door where temperature fluctuates. Keep away from direct ice contact. Check expiration dates; never use pens past the printed expiration date. If refrigeration is unavailable for more than a few hours, contact your healthcare provider.

What Happens to Semaglutide if Left in a Car?

A sealed pen left in a warm car (above 30°C for several hours) or freezing car (winter) risks significant degradation. For unopened pens, assess temperature exposure: 30-40°C for 1-2 hours has minimal impact; 4+ hours or higher temperatures (50°C+) may substantially degrade the product. An opened pen left in a hot environment faces similar risks. When in doubt, replace the pen.

Frequently Asked Questions